ing. E. (Eduard) Post
Practical Course Teacher and Research Assistant
E-mail:
Research
Research units:
Postal address:
A Deusinglaan
1
Gebouw 3214, ruimte 0302
Groningen
1
Gebouw 3214, ruimte 0302
Groningen
Netherlands
Phone: +31 50 363 7566Fax: +31 50 363 3247
Publications
The antifibrotic potential of a sustained release formulation of a PDGF beta-receptor targeted rho kinase inhibitor
van Dijk, F., Teekamp, N., Post, E., Schuppan, D., Kim, Y. O., Zuidema, J., Steendam, R., Klose, M. H. M., Meier-Menches, S. M., Casini, A., Horvatovich, P. L., Sijbrandi, N. J., Frijlink, H. W., Hinrichs, W. L. J., Poelstra, K., Beljaars, L. & Olinga, P., 28-Feb-2019, In : Journal of Controlled Release. 296, p. 250-257 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Towards clinical use of targeted therapies for liver fibrosis: development of a sustained release formulation for therapeutic proteins
Van Dijk, F., Teekamp, N., Beljaars, L., Post, E., Schuppan, D., Kim, Y. O., Poelstra, K., Frijlink, E., Hinrichs, W. & Olinga, P., 2017, In : Journal of Hepatology. 66, 1, p. S44-S44 1 p.Research output: Contribution to journal › Meeting Abstract › Academic
Pharmacokinetics of a sustained release formulation of PDGFβ-receptor directed carrier proteins to target the fibrotic liver
van Dijk, F., Teekamp, N., Beljaars, L., Post, E., Zuidema, J., Steendam, R., Kim, Y. O., Frijlink, H. W., Schuppand, D., Poelstra, K., Hinrichs, W. L. J. & Olinga, P., 10-Jan-2018, In : Journal of Controlled Release. 269, p. 258-265 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Therapeutic proteins in the treatment of liver fibrosis: The antifibrotic potential of a sustained release formulation for a PDGF beta-receptor targeted rho-kinase inhibitor
van Dijk, F., Teekamp, N., Beljaars, L., Post, E., Kim, Y. O., Frijlink, E., Hinrichs, W., Schuppan, D., Poelstra, K. & Olinga, P., Oct-2017, In : Hepatology. 66, p. 217A 1 p.Research output: Contribution to journal › Meeting Abstract › Academic
Polymeric microspheres for the sustained release of a protein-based drug carrier targeting the PDGFβ-receptor in the fibrotic kidney
Teekamp, N., Van Dijk, F., Broesder, A., Evers, M., Zuidema, J., Steendam, R., Post, E., Hillebrands, J. L., Frijlink, H. W., Poelstra, K., Beljaars, L., Olinga, P. & Hinrichs, W. L. J., 20-Dec-2017, In : International Journal of Pharmaceutics. 534, 1-2, p. 229-236 8 p.Research output: Contribution to journal › Article › Academic › peer-review
ID: 186189